Literature DB >> 23483522

Health economic evaluation: important principles and methodology.

Luke Rudmik1, Michael Drummond.   

Abstract

OBJECTIVES/HYPOTHESIS: To discuss health economic evaluation and improve the understanding of common methodology.
RESULTS: This article discusses the methodology for the following types of economic evaluations: cost-minimization, cost-effectiveness, cost-utility, cost-benefit, and economic modeling. Topics include health-state utility measures, the quality-adjusted life year (QALY), uncertainty analysis, discounting, decision tree analysis, and Markov modeling.
CONCLUSION: Economic evaluation is the comparative analysis of alternative courses of action in terms of both their costs and consequences. With increasing health care expenditure and limited resources, it is important for physicians to consider the economic impact of their interventions. Understanding common methodology involved in health economic evaluation will improve critical appraisal of the literature and optimize future economic evaluations.
Copyright © 2012 The American Laryngological, Rhinological and Otological Society, Inc.

Mesh:

Year:  2013        PMID: 23483522     DOI: 10.1002/lary.23943

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  34 in total

1.  Cost-Effectiveness Analysis of Breast Reconstruction Options in the Setting of Postmastectomy Radiotherapy Using the BREAST-Q.

Authors:  Shantanu N Razdan; Peter G Cordeiro; Claudia R Albornoz; Teresa Ro; Wess A Cohen; Babak J Mehrara; Colleen M McCarthy; Joseph J Disa; Andrea L Pusic; Evan Matros
Journal:  Plast Reconstr Surg       Date:  2016-03       Impact factor: 4.730

Review 2.  Functional outcomes assessment in shoulder surgery.

Authors:  James D Wylie; James T Beckmann; Erin Granger; Robert Z Tashjian
Journal:  World J Orthop       Date:  2014-11-18

3.  Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study.

Authors:  Lauren J Luk; Toby O Steele; Jess C Mace; Zachary M Soler; Luke Rudmik; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2015-07-03       Impact factor: 3.858

4.  Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis.

Authors:  Luke Rudmik; Zachary M Soler; Jess C Mace; Rodney J Schlosser; Timothy L Smith
Journal:  Laryngoscope       Date:  2014-09-03       Impact factor: 3.325

Review 5.  Economics of Chronic Rhinosinusitis.

Authors:  Luke Rudmik
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.806

6.  Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis.

Authors:  Luke Rudmik; Timothy L Smith; Jess C Mace; Rodney J Schlosser; Peter H Hwang; Zachary M Soler
Journal:  Laryngoscope       Date:  2015-09-15       Impact factor: 3.325

7.  Health utility values for patients with recurrent acute rhinosinusitis undergoing endoscopic sinus surgery: a nested case control study.

Authors:  Toby O Steele; Jess C Mace; Raj Dedhia; Luke Rudmik; Timothy L Smith; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2016-06-16       Impact factor: 3.858

8.  Simultaneous Bilateral Versus Staged Bilateral Carpal Tunnel Release: A Cost-effectiveness Analysis.

Authors:  Kevin W Park; Martin I Boyer; Richard H Gelberman; Ryan P Calfee; Jeffrey G Stepan; Daniel A Osei
Journal:  J Am Acad Orthop Surg       Date:  2016-11       Impact factor: 3.020

Review 9.  Economic evaluations addressing diagnosis and treatment strategies for neglected tropical diseases: an overview.

Authors:  Tália Machado de Assis; Ana Rabello; Gláucia Cota
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-05-24       Impact factor: 1.846

10.  Health Impairment From Nasal Airway Obstruction and Changes in Health Utility Values From Septorhinoplasty.

Authors:  Richard Tjahjono; Raquel Alvarado; Larry Kalish; Raymond Sacks; Raewyn Campbell; George Marcells; Carolyn Orgain; Richard John Harvey
Journal:  JAMA Facial Plast Surg       Date:  2019-03-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.